Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.36 |
| ▸ | PPARG | P37231 | 7/20 | 0.36 |
| ▸ | PPARD | Q03181 | 7/20 | 0.36 |
| ▸ | PPARA | Q07869 | 7/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TLR2 | O60603 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | FABP4 | P15090 | 2/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5418693 | 1.00 | GPR84 (0.36) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL786356 | 0.91 | EPHX2 (0.47) | PPARGPPARDPPARAPTPN1TDP1 | |
| SCHEMBL30413 | 0.81 | GPR84 (0.44) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5495040 | 0.81 | GPR84 (0.44) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5490197 | 0.81 | GPR84 (0.44) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL253962 | 0.81 | GPR84 (0.44) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL45203 | 0.81 | GPR84 (0.44) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL1273217 | 0.81 | GPR84 (0.44) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL18260639 | 0.81 | GPR84 (0.44) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5395520 | 0.79 | AKR1B1 (0.42) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070148220-A1 | Liposomes and liposomal compositions for vaccination and drug delivery | PHARMEXA A/S (DK) | 2007-06-28 | — | — | US | claimed |
| EP-1547581-A1 | Liposomal vaccine for the treatment of human hematological malignancies | Vectron Therapeutics AG (DE) | 2005-06-29 | — | — | EP | claimed |
| WO-2024022332-A1 | FAP INHIBITORS | SHANGHAI SINOTAU BIOTECH. CO., LTD (CN) | 2024-02-01 | — | — | WO | disclosed |
| WO-2023202655-A1 | FAP INHIBITORS | SHANGHAI SINOTAU BIOTECH. CO., LTD (CN) | 2023-10-26 | — | — | WO | disclosed |
| WO-2019154859-A1 | FAP INHIBITOR | Universität Heidelberg (DE) | 2019-08-15 | — | — | WO | disclosed |
| US-20070298093-A1 | Synergistic Liposomal Adjuvants | PHARMEXA A/S (DK) | 2007-12-27 | — | — | US | disclosed |
| US-20070148220-A1 | Liposomes and liposomal compositions for vaccination and drug delivery | PHARMEXA A/S (DK) | 2007-06-28 | — | — | US | disclosed |
| EP-1711205-A1 | SYNERGISTIC LIPOSOMAL ADJUVANTS | Pharmexa A/S (DK) | 2006-10-18 | — | — | EP | disclosed |
| EP-1696883-A2 | LIPOSOMES AND LIPOSOMAL COMPOSITIONS FOR VACCINATION AND DRUG DELIVERY | Pharmexa A/S (DK) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005063288-A1 | SYNERGISTIC LIPOSOMAL ADJUVANTS | PHARMEXA A/S (DK) | 2005-07-14 | — | — | WO | disclosed |
| WO-2005063201-A2 | LIPOSOMES AND LIPOSOMAL COMPOSITIONS FOR VACCINATION AND DRUG DELIVERY | PHARMEXA A/S (DK) | 2005-07-14 | — | — | WO | disclosed |
| EP-1550458-A1 | Synergistic liposomal adjuvants | Vectron Therapeutics AG (DE) | 2005-07-06 | — | — | EP | disclosed |
| EP-1547581-A1 | Liposomal vaccine for the treatment of human hematological malignancies | Vectron Therapeutics AG (DE) | 2005-06-29 | — | — | EP | disclosed |